Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroblastoma.

K B Angstman1, J S Miser, W B Franz

  • 1Mayo Graduate School of Medicine, Rochester, Minnesota.

American Family Physician
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Neuroblastoma is a rare pediatric cancer originating in the sympathetic nervous system. This case highlights key aspects of neuroblastoma presentation, diagnosis, and treatment in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation in real life: lessons from MERS-CoV in Thailand.

The Journal of hospital infection·2016
Same author

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Journal of pediatric hematology/oncology·2001
Same author

Successful dose-intensive treatment of desmoplastic small round cell tumor in three children.

Journal of pediatric hematology/oncology·2000
Same author

Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection.

The Journal of thoracic and cardiovascular surgery·2000
Same author

Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.

European journal of cancer (Oxford, England : 1990)·2000
Same author

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.

Medical and pediatric oncology·1999
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Neuroscience
  • Cancer Biology

Background:

  • Neuroblastoma is a significant pediatric malignancy, comprising 8% of childhood tumors.
  • It is the leading cause of cancer-related deaths in children, accounting for 11% of fatalities.
  • Typically diagnosed in children under four years old, with rare occurrences after age 14.

Observation:

  • Clinical presentation of neuroblastoma is highly variable.
  • Symptoms depend on the tumor's location and its stage of development.
  • This case study details the typical presentation, diagnostic process, and therapeutic interventions.

Findings:

  • The study illustrates the characteristic clinical manifestations of neuroblastoma.
  • It details the diagnostic procedures employed for this specific cancer.

Related Experiment Videos

  • Treatment strategies for neuroblastoma are presented within the case context.

    • Implications:

    • Understanding neuroblastoma's presentation is crucial for early diagnosis.
    • Effective diagnostic and treatment protocols are vital for improving outcomes.
    • This case contributes to the knowledge base for managing pediatric sympathetic nervous system tumors.